The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?
Articolo
Data di Pubblicazione:
2021
Citazione:
The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? / G. Damiani, A. Pacifico, F. Pelloni, M. Iorizzo. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - (2021). [Epub ahead of print] [10.1111/jdv.17472]
Abstract:
During the COVID-19 pandemics the management of immunosuppressed patients, such as those affected by autoimmune bullous diseases (AIBDs), became a matter of particular concern for healthcare systems; dissemination of sound and updated information became mandatory to orient physicians and, more generally healthcare policy [1,2]. Furthermore, AIBDs patients were encouraged take advantage from teledermatological rather than in-person consultations; also, they were encouraged to undergo COVID-19 vaccination, preferably during remission periods or at least while under low immunosuppression [3,4].
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
COVID-19 pandemic; COVID-19 vaccine; SARS-CoV-2; bullous pemphigoid; pemphigus; safety; teledermatology
Elenco autori:
G. Damiani, A. Pacifico, F. Pelloni, M. Iorizzo
Link alla scheda completa:
Link al Full Text: